Horizon Kinetics’s Celgene Corp CELG Stock Holding History

Horizon Kinetics’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$450K	Sell	7,019 -11	-0.2%	-$812	0.01%	254
2018 Q3	$629K	Hold	7,030	–	–	0.02%	244
2018 Q2	$558K	Buy	7,030 +30	+0.4%	+$2.49K	0.01%	253
2018 Q1	$624K	Sell	7,000 -900	-11%	-$86.4K	0.02%	242
2017 Q4	$825K	Sell	7,900 -39	-0.5%	-$4.4K	0.02%	210
2017 Q3	$1.16M	Sell	7,939 -216	-3%	-$29.4K	0.03%	171
2017 Q2	$1.06M	Buy	8,155 +155	+2%	+$19K	0.03%	187
2017 Q1	$995K	Hold	8,000	–	–	0.03%	192
2016 Q4	$926K	Hold	8,000	–	–	0.03%	199
2016 Q3	$837K	Hold	8,000	–	–	0.02%	220
2016 Q2	$789K	Hold	8,000	–	–	0.02%	241
2016 Q1	$801K	Hold	8,000	–	–	0.02%	231
2015 Q4	$958K	Hold	8,000	–	–	0.02%	206
2015 Q3	$865K	Buy	8,000 +3,000	+60%	+$372K	0.02%	214
2015 Q2	$579K	Hold	5,000	–	–	0.01%	388
2015 Q1	$576K	Buy	+5,000	New	+$597K	0.01%	392

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Horizon Kinetics's CELG Position: Q4 2018 in Review

Horizon Kinetics reduced its Celgene Corp (CELG) stake by 0.16% in Q4 2018, selling an estimated $812 and leaving 7,019 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #254.

Horizon Kinetics first reported a position in CELG in Q1 2015 and has held it in 16 quarters since. The position peaked at $1.16M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Horizon Kinetics held 7,019 shares of Celgene Corp worth $450K as of Q4 2018.
Horizon Kinetics sold 11 Celgene Corp shares in Q4 2018, an estimated $812.
Celgene Corp made up 0.01% of Horizon Kinetics's portfolio in Q4 2018, its #254 holding.
Horizon Kinetics first reported a position in Celgene Corp in Q1 2015 and has held it in 16 quarters since.
Horizon Kinetics's Celgene Corp position peaked at $1.16M in Q3 2017.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.